Literature DB >> 23435790

EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases.

Lars Lind1, Sölve Elmståhl, Ebba Bergman, Martin Englund, Eva Lindberg, Karl Michaelsson, Peter M Nilsson, Johan Sundström.   

Abstract

The most common diseases affecting middle-aged and elderly subjects in industrialized countries are multigenetic and lifestyle related. Several attempts have been made to study interactions between genes and lifestyle factors, but most such studies lack the power to examine interactions between several genes and several lifestyle components. The primary objective of the EpiHealth cohort study is to provide a resource to study interactions between several genotypes and lifestyle factors in a large cohort (the aim is 300,000 individuals) derived from the Swedish population in the age range of 45-75 years regarding development of common degenerative disorders, such as cardiovascular diseases, cancer, dementia, joint pain, obstructive lung disease, depression, and osteoporotic fractures. The study consists of three parts. First, a collection of data on lifestyle factors by self-assessment using an internet-based questionnaire. Second, a visit to a test center where blood samples are collected and physiological parameters recorded. Third, the sample is followed for occurrence of outcomes using nationwide medical registers. This overview presents the study design and some baseline characteristics from the first year of data collection in the EpiHealth study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23435790     DOI: 10.1007/s10654-013-9787-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

1.  Genetics meets environment: evaluating gene-environment interactions in neurologic diseases.

Authors:  Connie Marras; Samuel M Goldman
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

2.  Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC).

Authors:  Zhengming Chen; Liming Lee; Junshi Chen; Rory Collins; Fan Wu; Yu Guo; Pamela Linksted; Richard Peto
Journal:  Int J Epidemiol       Date:  2005-08-30       Impact factor: 7.196

Review 3.  The BioBank Japan Project.

Authors:  Yusuke Nakamura
Journal:  Clin Adv Hematol Oncol       Date:  2007-09

4.  Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.

Authors:  Ronald P Stolk; Judith G M Rosmalen; Dirkje S Postma; Rudolf A de Boer; Gerjan Navis; Joris P J Slaets; Johan Ormel; Bruce H R Wolffenbuttel
Journal:  Eur J Epidemiol       Date:  2007-12-13       Impact factor: 8.082

5.  European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures--a GA2LEN initiative.

Authors:  T Keil; M Kulig; A Simpson; A Custovic; M Wickman; I Kull; K C Lødrup Carlsen; K H Carlsen; H A Smit; A H Wijga; S Schmid; A Von Berg; C Bollrath; E Eller; C Bindslev-Jensen; S Halken; A Høst; J Heinrich; M P Fantini; B Brunekreef; U Krämer; S N Willich; U Wahn; S Lau
Journal:  Allergy       Date:  2006-09       Impact factor: 13.146

6.  The National Children's Study: a 21-year prospective study of 100,000 American children.

Authors:  Philip J Landrigan; Leonardo Trasande; Lorna E Thorpe; Charon Gwynn; Paul J Lioy; Mary E D'Alton; Heather S Lipkind; James Swanson; Pathik D Wadhwa; Edward B Clark; Virginia A Rauh; Frederica P Perera; Ezra Susser
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

7.  Population genomics: laying the groundwork for genetic disease modeling and targeting.

Authors:  J Gulcher; K Stefansson
Journal:  Clin Chem Lab Med       Date:  1998-08       Impact factor: 3.694

8.  Reference values for 27 clinical chemistry tests in 70-year-old males and females.

Authors:  Lena Carlsson; Lars Lind; Anders Larsson
Journal:  Gerontology       Date:  2009-10-21       Impact factor: 5.140

9.  The case for a US prospective cohort study of genes and environment.

Authors:  Francis S Collins
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

10.  Cohort profile: cohort of Norway (CONOR).

Authors:  Oyvind Naess; Anne Johanne Søgaard; Egil Arnesen; Anne Cathrine Beckstrøm; Espen Bjertness; Anders Engeland; Peter F Hjort; Jostein Holmen; Per Magnus; Inger Njølstad; Grethe S Tell; Lars Vatten; Stein Emil Vollset; Geir Aamodt
Journal:  Int J Epidemiol       Date:  2007-11-04       Impact factor: 7.196

View more
  21 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Association Between Self-Reported Sleep Duration and Body Composition in Middle-Aged and Older Adults.

Authors:  Xiao Tan; Olga E Titova; Eva Lindberg; Sölve Elmståhl; Lars Lind; Helgi B Schiöth; Christian Benedict
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

3.  Cardiometabolic Proteins Associated with Metabolic Syndrome.

Authors:  Lars Lind; Sölve Elmståhl; Erik Ingelsson
Journal:  Metab Syndr Relat Disord       Date:  2019-03-18       Impact factor: 1.894

4.  Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women.

Authors:  Amy E Mendham; Lisa K Micklesfield; Fredrik Karpe; Andre Pascal Kengne; Tinashe Chikowore; Clement N Kufe; Maphoko Masemola; Nigel J Crowther; Shane A Norris; Tommy Olsson; Sölve Elmståhl; Tove Fall; Lars Lind; Julia H Goedecke
Journal:  Diabetologia       Date:  2022-09-17       Impact factor: 10.460

5.  Associations of Circulating Protein Levels With Lipid Fractions in the General Population.

Authors:  Sylwia M Figarska; Stefan Gustafsson; Johan Sundström; Johan Ärnlöv; Anders Mälarstig; Sölve Elmståhl; Tove Fall; Lars Lind; Erik Ingelsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

6.  Sleep duration is associated with healthy diet scores and meal patterns: results from the population-based EpiHealth study.

Authors:  Jenny Theorell-Haglöw; Eva Warensjö Lemming; Karl Michaëlsson; Sölve Elmståhl; Lars Lind; Eva Lindberg
Journal:  J Clin Sleep Med       Date:  2019-11-26       Impact factor: 4.062

7.  The Swedish CArdioPulmonary BioImage Study: objectives and design.

Authors:  G Bergström; G Berglund; A Blomberg; J Brandberg; G Engström; J Engvall; M Eriksson; U de Faire; A Flinck; M G Hansson; B Hedblad; O Hjelmgren; C Janson; T Jernberg; Å Johnsson; L Johansson; L Lind; C-G Löfdahl; O Melander; C J Östgren; A Persson; M Persson; A Sandström; C Schmidt; S Söderberg; J Sundström; K Toren; A Waldenström; H Wedel; J Vikgren; B Fagerberg; A Rosengren
Journal:  J Intern Med       Date:  2015-06-19       Impact factor: 8.989

8.  A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors.

Authors:  Jan P Dumanski; Chiara Rasi; Peyman Björklund; Hanna Davies; Abir S Ali; Malin Grönberg; Staffan Welin; Halfdan Sorbye; Henning Grønbæk; Janet L Cunningham; Lars A Forsberg; Lars Lind; Erik Ingelsson; Peter Stålberg; Per Hellman; Eva Tiensuu Janson
Journal:  Endocr Relat Cancer       Date:  2017-06-20       Impact factor: 5.678

9.  Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers.

Authors:  Prasad G Kamble; Stefan Gustafsson; Maria J Pereira; Per Lundkvist; Naomi Cook; Lars Lind; Paul W Franks; Tove Fall; Jan W Eriksson; Erik Ingelsson
Journal:  Ups J Med Sci       Date:  2018-01-05       Impact factor: 2.384

10.  The Rotterdam Scan Study: design update 2016 and main findings.

Authors:  M Arfan Ikram; Aad van der Lugt; Wiro J Niessen; Peter J Koudstaal; Gabriel P Krestin; Albert Hofman; Daniel Bos; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-12-09       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.